AstraZeneca Applies For EU Approval Of COVID-19 Vaccine
UK’s Controversial Dosing Schedule For Pfizer/BioNTech Jab May Face Legal Scrutiny
Executive Summary
The European Medicines Agency may issue an opinion on approving AstraZeneca’s COVID-19 vaccine by 29 January if the data are robust and complete and any additional data requests are dealt with promptly.
You may also be interested in...
Coronavirus Notebook: EU To Buy 30 Million Doses Of Valneva Vaccine, Russia To Issue Compulsory License For Remdesivir
The European Medicines Agency says hacked COVID-19 vaccine data has been leaked online, and Australia’s chief medical officer defends the Oxford/AstraZeneca vaccine against scientists’ claim that it is not effective enough.
EU Parliamentarians To Get Sight Of First COVID-19 Vaccine Contract
The advance purchase agreement signed by CureVac and the European Commission for the supply of a coronavirus vaccine is being made available for scrutiny, but only by MEPs and in the confines of the European Parliament.
EU Approval Of Oxford/AstraZeneca COVID-19 Vaccine Expected By End Of January
AstraZeneca is expected to apply for the EU approval of its COVID-19 vaccine next week. The vaccine was developed in partnership with the University of Oxford.